Risks and Predictors of Stroke After Transient Ischemic Attack

Professor of Neurology, Director of the Stroke Program, Northwestern University Medical School, Northwestern Memorial Hospital, Chicago, Illinois

Disclosure: Mark J. Alberts, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AGA Medical Corporation; AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; EKR Therapeutics Inc.; Genentech, Inc.; Pfizer Inc.; sanofi-aventis; Takeda Pharmaceuticals North America, Inc.; The Medicines Company
Received grants for clinical research from: AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; EKR Therapeutics Inc.; PhotoThera; sanofi-aventis; Schering-Plough Corporation
Served as a speaker or a member of a speakers bureau for: AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; diaDexus, Inc.; EKR Therapeutics Inc.; Genentech, Inc.; sanofi-aventis; The Medicines Company
Served on the review panel for: Mitsubishi Pharma America, Inc.; Schering-Plough Corporation
Received royalties from: Duke University/Athena Neurosciences, Inc. for ApoE Genotype test